We sought to use the approach in the following research by changing the model into PD-1 high expression tumor infiltrating lymphocytes in solid tumors or tumor associated lymphocytes in ascites or pleural effusion of cancer patients, as they expose intensively to tumor antigens and acquired adaptive immune resistance that mediates resistance to immunotherapies37. Here, PDCD1 is linked to cancer.